Publications
89
Citations
862
Est. group size
~2
Recurring co-author estimate
Active years
32
Publishing since 1995
This researcher's publication record spans a mix of topics, including a mouse-model study of prostate cancer biology (looking at how MYC gene activation and loss of the PTEN tumor suppressor gene contribute to aggressive precancerous lesions), as well as clinical and meta-analysis work on cardiovascular topics such as atrial fibrillation ablation, coronary artery imaging, pulmonary hypertension, and venous blood clot risk in sickle cell disease. The work combines basic cancer biology with clinical/epidemiological research across several medical subfields, often through systematic reviews and meta-analyses.
Publication output has grown substantially over the last decade, rising from about 1 paper per year in 2017 to an average of 11 per year in the last 5 years, with a notable spike in 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figure 3 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Table 5 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Data from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Figure 2 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Table 4 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Figure 7 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Table 2 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Figure 4 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Table 1 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Figure 5 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Table 3 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Figure 6 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- Supplementary Figure 1 from Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate
2026
- 500.24 Intracardiac (ICE) Vs Transesophageal Echocardiography (TEE) In Atrial Fibrillation (AF) Ablation for Left Atrial Appendage (LAA) Thrombus Visualization - A Systematic Review and Meta-Analysis
JACC: Cardiovascular Interventions · 2026
- Risk factors for venous thromboembolism in sickle cell disease
Research and Practice in Thrombosis and Haemostasis · 2026
- Blood×10
- Research and Practice in Thrombosis and Haemostasis×7
- Neurology×3
- Expert Review of Clinical Immunology×2
- The Egyptian Journal of Otolaryngology×2
- Craig J. Burd
Medicine · The Ohio State University
- Ashorne K. Mahenthiran
Medicine · Indiana University
- Andrés Acosta
Medicine · Indiana University
- Adeoluwa A. Adeluola
Medicine · The Ohio State University
- Dinuka De Silva
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile